TIGANEX 50mg INJ, Effective Antibiotics at Attractive Price

ವಿಚಾರಣೆಯನ್ನು ಕಳುಹಿಸಿ

Request To Call Back

Price 4327.17 INR/ Number

ಬೆಲೆ/ಉಲ್ಲೇಖ ಪಡೆಯಿರಿ

MOQ : 1 Number

Specification

ಡೋಸೇಜ್ ಫಾರ್ಮ್
Injection

ಔಷಧದ ಮೂಲ
Allopathic

ಉಪ್ಪು ಸಂಯೋಜನೆ
Tigecycline

ಪ್ಯಾಕೇಜಿಂಗ್ (ಪ್ರತಿ ಪೆಟ್ಟಿಗೆಗೆ ಪ್ರಮಾಣ)
1 Vial per box

ಸೂಚನೆ
Complicated skin and soft tissue infections, intra-abdominal infections

ಡ್ರಗ್ ವಿಧ

ಪದಾರ್ಥಗಳು
Tigecycline 50mg

ಶಾರೀರಿಕ ರೂಪ

ಕಾರ್ಯ

ಇದಕ್ಕಾಗಿ ಶಿಫಾರಸು ಮಾಡಲಾಗಿದೆ
Adults with complicated infections

ಡೋಸೇಜ್
50 mg every 12 hours after initial loading dose

ಡೋಸೇಜ್ ಮಾರ್ಗಸೂಚಿಗಳು
As directed by the physician

ಸೂಕ್ತವಾಗಿದೆ

ಪ್ರಮಾಣ
1 Vial

ಶೇಖರಣಾ ಸೂಚನೆಗಳು
Store below 25°C, protect from light

About

Find unparalleled value with TIGANEX 50mg INJ, a kingly choice in first-class hospital antibiotics. Formulated with 50 mg of tigecycline per vial, this lyophilized powder presents as yellow to orange and offers an uncompromising hot deal on effective, broad-spectrum antibacterial coverage. Designed for intravenous administration, it meets exacting standards in the management of complex skin and intra-abdominal infections in adults. Experience confidence with a prescription-only solution that embodies reliability, efficacy, and safety, delivering optimal outcomes for healthcare professionals and patients alike.

Targeted Action for Complicated Infections

TIGANEX 50mg INJ is specifically tailored for adults with complicated skin, soft tissue, or intra-abdominal infections. As a glycylcycline antibiotic, it is used in hospital settings where prompt, potent antibacterial intervention is required. Its general use, guided by physicians, ensures effective management of severe infections that demand an advanced, first-class approach to antibiotic therapy. This makes TIGANEX an integral asset in critical care and infectious disease treatment protocols.

Certifications and Reliable Supply Assurance

TIGANEX 50mg INJ comes with quality assurance and reliable certifications, ensuring it meets strict medical and regulatory standards. Stock is ready for immediate dispatch, and our secure shipping methods guarantee prompt, protected delivery. We welcome inquiries regarding asking price and sample policy, tailored to healthcare procurement needs. With dependable supply ability, TIGANEX is an ideal choice for distributors, traders, and hospitals seeking trustworthy inventory for advanced infection management.

Specification

Medicine Type	Allopathic Medicine
Storage Condition	Store Below 30 Degree C
Country of Origin	Made in India
Shelf Life	2 Year
Form	Injection
Manufacturer	Cipla Ltd
Brand	Tiganex
Packaging Size	1 Vial
Prescription/Non prescription	Prescription
Composition	Tigecycline

FAQ's of TIGANEX 50mg INJ:

Q: How should TIGANEX 50mg INJ be administered?

A: TIGANEX 50mg INJ is to be administered intravenously after reconstitution with 5.3 mL of 0.9% Sodium Chloride or 5% Dextrose. Strictly for hospital use under medical supervision.

Q: What are the primary indications for using TIGANEX 50mg INJ?

A: This antibiotic is indicated for treatment of adults with complicated skin, soft tissue, or intra-abdominal infections. It is not recommended for pediatric or pregnant patients.

Q: When is TIGANEX 50mg INJ prescribed?

A: TIGANEX 50mg INJ is prescribed when advanced infection requires potent, broad-spectrum antibiotic therapy, especially in cases not responding to other treatments.

Q: Where should TIGANEX 50mg INJ be stored before use?

A: Store below 25C and protect from light. Ensure it remains in a secure hospital environment and follow prescribed storage guidelines to maintain its efficacy.

Q: What process is followed for the reconstitution of TIGANEX 50mg INJ?

A: Reconstitute the lyophilized powder by adding 5.3 mL of 0.9% Sodium Chloride or 5% Dextrose, following strict aseptic techniques as instructed by the manufacturer.

Q: What benefits does TIGANEX 50mg INJ offer for infection management?

A: TIGANEX offers unparalleled benefits by providing broad-spectrum antibacterial coverage for challenging infections, ensuring first-class outcomes in critical care scenarios.

Tell us about your requirement